avibactam/aztreonam (Emblaveo)
Jump to navigation
Jump to search
Indications
- intra-abdominal infections
- for use in combination with metronidazole
Adverse effects
- adverse hepatic reactions, anemia, diarrhea, hypokalemia, pyrexia
More general terms
References
- ↑ Bassett M FDA OKs New Antibiotic Combo for Complicated Intra-Abdominal Infections. Such infections include those caused by Gram-negative bacteria. MedPage Today February 7, 2025 https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/114136
Carmeli Y, Cisneros JM, Paul M et al Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial.. Lancet Infect Dis. 2025 Feb;25(2):218-230. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00499-7/abstract PMID: https://www.ncbi.nlm.nih.gov/pubmed/39389071 Clinical Trial.